Global Point-of-Care Infectious Disease Diagnostics & Testing Market Growth (Status and Outlook) 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Point-of-Care Infectious Disease Diagnostics & Testing market size was valued at US$ 2008.9 million in 2023. With growing demand in downstream market, the Point-of-Care Infectious Disease Diagnostics & Testing is forecast to a readjusted size of US$ 2745.7 million by 2030 with a CAGR of 4.6% during review period.
The research report highlights the growth potential of the global Point-of-Care Infectious Disease Diagnostics & Testing market. Point-of-Care Infectious Disease Diagnostics & Testing are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Point-of-Care Infectious Disease Diagnostics & Testing. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Point-of-Care Infectious Disease Diagnostics & Testing market.
A point-of-care (POC) test is performed at or near the site where a patient initially encounters the health care system, has a rapid turnaround time (approximately 15 min), and provides actionable information that can lead to a change in patient management.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Point-of-Care Infectious Disease Diagnostics & Testing market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Point-of-Care Infectious Disease Diagnostics & Testing market. It may include historical data, market segmentation by Type (e.g., HIV POC, Clostridium difficile POC), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Point-of-Care Infectious Disease Diagnostics & Testing market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Point-of-Care Infectious Disease Diagnostics & Testing market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Point-of-Care Infectious Disease Diagnostics & Testing industry. This include advancements in Point-of-Care Infectious Disease Diagnostics & Testing technology, Point-of-Care Infectious Disease Diagnostics & Testing new entrants, Point-of-Care Infectious Disease Diagnostics & Testing new investment, and other innovations that are shaping the future of Point-of-Care Infectious Disease Diagnostics & Testing.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Point-of-Care Infectious Disease Diagnostics & Testing market. It includes factors influencing customer ' purchasing decisions, preferences for Point-of-Care Infectious Disease Diagnostics & Testing product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Point-of-Care Infectious Disease Diagnostics & Testing market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Point-of-Care Infectious Disease Diagnostics & Testing market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Point-of-Care Infectious Disease Diagnostics & Testing market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Point-of-Care Infectious Disease Diagnostics & Testing industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Point-of-Care Infectious Disease Diagnostics & Testing market.
Market Segmentation:
Point-of-Care Infectious Disease Diagnostics & Testing market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
According to our LPI (LP Information) latest study, the global Point-of-Care Infectious Disease Diagnostics & Testing market size was valued at US$ 2008.9 million in 2023. With growing demand in downstream market, the Point-of-Care Infectious Disease Diagnostics & Testing is forecast to a readjusted size of US$ 2745.7 million by 2030 with a CAGR of 4.6% during review period.
The research report highlights the growth potential of the global Point-of-Care Infectious Disease Diagnostics & Testing market. Point-of-Care Infectious Disease Diagnostics & Testing are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Point-of-Care Infectious Disease Diagnostics & Testing. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Point-of-Care Infectious Disease Diagnostics & Testing market.
A point-of-care (POC) test is performed at or near the site where a patient initially encounters the health care system, has a rapid turnaround time (approximately 15 min), and provides actionable information that can lead to a change in patient management.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Point-of-Care Infectious Disease Diagnostics & Testing market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Point-of-Care Infectious Disease Diagnostics & Testing market. It may include historical data, market segmentation by Type (e.g., HIV POC, Clostridium difficile POC), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Point-of-Care Infectious Disease Diagnostics & Testing market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Point-of-Care Infectious Disease Diagnostics & Testing market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Point-of-Care Infectious Disease Diagnostics & Testing industry. This include advancements in Point-of-Care Infectious Disease Diagnostics & Testing technology, Point-of-Care Infectious Disease Diagnostics & Testing new entrants, Point-of-Care Infectious Disease Diagnostics & Testing new investment, and other innovations that are shaping the future of Point-of-Care Infectious Disease Diagnostics & Testing.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Point-of-Care Infectious Disease Diagnostics & Testing market. It includes factors influencing customer ' purchasing decisions, preferences for Point-of-Care Infectious Disease Diagnostics & Testing product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Point-of-Care Infectious Disease Diagnostics & Testing market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Point-of-Care Infectious Disease Diagnostics & Testing market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Point-of-Care Infectious Disease Diagnostics & Testing market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Point-of-Care Infectious Disease Diagnostics & Testing industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Point-of-Care Infectious Disease Diagnostics & Testing market.
Market Segmentation:
Point-of-Care Infectious Disease Diagnostics & Testing market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
- HIV POC
- Clostridium difficile POC
- HBV POC
- Pneumonia or Streptococcus associated infections
- Respiratory syncytial virus (RSV) POC
- HPV POC
- Influenza/Flu POC
- Other Infectious Disease POC
- Hospitals
- Clinics
- Home
- Assisted Living Healthcare Facilities
- Laboratories
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Abbott
- Thermo Fisher Scientific Inc
- Roche
- Siemens Healthineers
- BD & Company
- Chembio Diagnostics Inc.
- Trinity Biotech
- Cardinal Health
- Quest Diagnostics Inc.
- Bio-Rad Labs Inc.
- bioMйrieux SA
- Sight Diagnostics Ltd.
- Gene POC
- Trivitron Healthcare
- OJ-Bio Ltd.
- Ortho-Clinical Diagnostics
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Point-of-Care Infectious Disease Diagnostics & Testing Market Size 2019-2030
2.1.2 Point-of-Care Infectious Disease Diagnostics & Testing Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Point-of-Care Infectious Disease Diagnostics & Testing Segment by Type
2.2.1 HIV POC
2.2.2 Clostridium difficile POC
2.2.3 HBV POC
2.2.4 Pneumonia or Streptococcus associated infections
2.2.5 Respiratory syncytial virus (RSV) POC
2.2.6 HPV POC
2.2.7 Influenza/Flu POC
2.2.8 Other Infectious Disease POC
2.3 Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Type
2.3.1 Point-of-Care Infectious Disease Diagnostics & Testing Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Point-of-Care Infectious Disease Diagnostics & Testing Market Size Market Share by Type (2019-2024)
2.4 Point-of-Care Infectious Disease Diagnostics & Testing Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Home
2.4.4 Assisted Living Healthcare Facilities
2.4.5 Laboratories
2.4.6 Others
2.5 Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Application
2.5.1 Point-of-Care Infectious Disease Diagnostics & Testing Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Point-of-Care Infectious Disease Diagnostics & Testing Market Size Market Share by Application (2019-2024)
3 POINT-OF-CARE INFECTIOUS DISEASE DIAGNOSTICS & TESTING MARKET SIZE BY PLAYER
3.1 Point-of-Care Infectious Disease Diagnostics & Testing Market Size Market Share by Players
3.1.1 Global Point-of-Care Infectious Disease Diagnostics & Testing Revenue by Players (2019-2024)
3.1.2 Global Point-of-Care Infectious Disease Diagnostics & Testing Revenue Market Share by Players (2019-2024)
3.2 Global Point-of-Care Infectious Disease Diagnostics & Testing Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 POINT-OF-CARE INFECTIOUS DISEASE DIAGNOSTICS & TESTING BY REGIONS
4.1 Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Regions (2019-2024)
4.2 Americas Point-of-Care Infectious Disease Diagnostics & Testing Market Size Growth (2019-2024)
4.3 APAC Point-of-Care Infectious Disease Diagnostics & Testing Market Size Growth (2019-2024)
4.4 Europe Point-of-Care Infectious Disease Diagnostics & Testing Market Size Growth (2019-2024)
4.5 Middle East & Africa Point-of-Care Infectious Disease Diagnostics & Testing Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Country (2019-2024)
5.2 Americas Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Type (2019-2024)
5.3 Americas Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Region (2019-2024)
6.2 APAC Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Type (2019-2024)
6.3 APAC Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Point-of-Care Infectious Disease Diagnostics & Testing by Country (2019-2024)
7.2 Europe Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Type (2019-2024)
7.3 Europe Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Point-of-Care Infectious Disease Diagnostics & Testing by Region (2019-2024)
8.2 Middle East & Africa Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Type (2019-2024)
8.3 Middle East & Africa Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL POINT-OF-CARE INFECTIOUS DISEASE DIAGNOSTICS & TESTING MARKET FORECAST
10.1 Global Point-of-Care Infectious Disease Diagnostics & Testing Forecast by Regions (2025-2030)
10.1.1 Global Point-of-Care Infectious Disease Diagnostics & Testing Forecast by Regions (2025-2030)
10.1.2 Americas Point-of-Care Infectious Disease Diagnostics & Testing Forecast
10.1.3 APAC Point-of-Care Infectious Disease Diagnostics & Testing Forecast
10.1.4 Europe Point-of-Care Infectious Disease Diagnostics & Testing Forecast
10.1.5 Middle East & Africa Point-of-Care Infectious Disease Diagnostics & Testing Forecast
10.2 Americas Point-of-Care Infectious Disease Diagnostics & Testing Forecast by Country (2025-2030)
10.2.1 United States Point-of-Care Infectious Disease Diagnostics & Testing Market Forecast
10.2.2 Canada Point-of-Care Infectious Disease Diagnostics & Testing Market Forecast
10.2.3 Mexico Point-of-Care Infectious Disease Diagnostics & Testing Market Forecast
10.2.4 Brazil Point-of-Care Infectious Disease Diagnostics & Testing Market Forecast
10.3 APAC Point-of-Care Infectious Disease Diagnostics & Testing Forecast by Region (2025-2030)
10.3.1 China Point-of-Care Infectious Disease Diagnostics & Testing Market Forecast
10.3.2 Japan Point-of-Care Infectious Disease Diagnostics & Testing Market Forecast
10.3.3 Korea Point-of-Care Infectious Disease Diagnostics & Testing Market Forecast
10.3.4 Southeast Asia Point-of-Care Infectious Disease Diagnostics & Testing Market Forecast
10.3.5 India Point-of-Care Infectious Disease Diagnostics & Testing Market Forecast
10.3.6 Australia Point-of-Care Infectious Disease Diagnostics & Testing Market Forecast
10.4 Europe Point-of-Care Infectious Disease Diagnostics & Testing Forecast by Country (2025-2030)
10.4.1 Germany Point-of-Care Infectious Disease Diagnostics & Testing Market Forecast
10.4.2 France Point-of-Care Infectious Disease Diagnostics & Testing Market Forecast
10.4.3 UK Point-of-Care Infectious Disease Diagnostics & Testing Market Forecast
10.4.4 Italy Point-of-Care Infectious Disease Diagnostics & Testing Market Forecast
10.4.5 Russia Point-of-Care Infectious Disease Diagnostics & Testing Market Forecast
10.5 Middle East & Africa Point-of-Care Infectious Disease Diagnostics & Testing Forecast by Region (2025-2030)
10.5.1 Egypt Point-of-Care Infectious Disease Diagnostics & Testing Market Forecast
10.5.2 South Africa Point-of-Care Infectious Disease Diagnostics & Testing Market Forecast
10.5.3 Israel Point-of-Care Infectious Disease Diagnostics & Testing Market Forecast
10.5.4 Turkey Point-of-Care Infectious Disease Diagnostics & Testing Market Forecast
10.5.5 GCC Countries Point-of-Care Infectious Disease Diagnostics & Testing Market Forecast
10.6 Global Point-of-Care Infectious Disease Diagnostics & Testing Forecast by Type (2025-2030)
10.7 Global Point-of-Care Infectious Disease Diagnostics & Testing Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Abbott
11.1.1 Abbott Company Information
11.1.2 Abbott Point-of-Care Infectious Disease Diagnostics & Testing Product Offered
11.1.3 Abbott Point-of-Care Infectious Disease Diagnostics & Testing Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Abbott Main Business Overview
11.1.5 Abbott Latest Developments
11.2 Thermo Fisher Scientific Inc
11.2.1 Thermo Fisher Scientific Inc Company Information
11.2.2 Thermo Fisher Scientific Inc Point-of-Care Infectious Disease Diagnostics & Testing Product Offered
11.2.3 Thermo Fisher Scientific Inc Point-of-Care Infectious Disease Diagnostics & Testing Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Thermo Fisher Scientific Inc Main Business Overview
11.2.5 Thermo Fisher Scientific Inc Latest Developments
11.3 Roche
11.3.1 Roche Company Information
11.3.2 Roche Point-of-Care Infectious Disease Diagnostics & Testing Product Offered
11.3.3 Roche Point-of-Care Infectious Disease Diagnostics & Testing Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Roche Main Business Overview
11.3.5 Roche Latest Developments
11.4 Siemens Healthineers
11.4.1 Siemens Healthineers Company Information
11.4.2 Siemens Healthineers Point-of-Care Infectious Disease Diagnostics & Testing Product Offered
11.4.3 Siemens Healthineers Point-of-Care Infectious Disease Diagnostics & Testing Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Siemens Healthineers Main Business Overview
11.4.5 Siemens Healthineers Latest Developments
11.5 BD & Company
11.5.1 BD & Company Company Information
11.5.2 BD & Company Point-of-Care Infectious Disease Diagnostics & Testing Product Offered
11.5.3 BD & Company Point-of-Care Infectious Disease Diagnostics & Testing Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 BD & Company Main Business Overview
11.5.5 BD & Company Latest Developments
11.6 Chembio Diagnostics Inc.
11.6.1 Chembio Diagnostics Inc. Company Information
11.6.2 Chembio Diagnostics Inc. Point-of-Care Infectious Disease Diagnostics & Testing Product Offered
11.6.3 Chembio Diagnostics Inc. Point-of-Care Infectious Disease Diagnostics & Testing Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Chembio Diagnostics Inc. Main Business Overview
11.6.5 Chembio Diagnostics Inc. Latest Developments
11.7 Trinity Biotech
11.7.1 Trinity Biotech Company Information
11.7.2 Trinity Biotech Point-of-Care Infectious Disease Diagnostics & Testing Product Offered
11.7.3 Trinity Biotech Point-of-Care Infectious Disease Diagnostics & Testing Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Trinity Biotech Main Business Overview
11.7.5 Trinity Biotech Latest Developments
11.8 Cardinal Health
11.8.1 Cardinal Health Company Information
11.8.2 Cardinal Health Point-of-Care Infectious Disease Diagnostics & Testing Product Offered
11.8.3 Cardinal Health Point-of-Care Infectious Disease Diagnostics & Testing Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Cardinal Health Main Business Overview
11.8.5 Cardinal Health Latest Developments
11.9 Quest Diagnostics Inc.
11.9.1 Quest Diagnostics Inc. Company Information
11.9.2 Quest Diagnostics Inc. Point-of-Care Infectious Disease Diagnostics & Testing Product Offered
11.9.3 Quest Diagnostics Inc. Point-of-Care Infectious Disease Diagnostics & Testing Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Quest Diagnostics Inc. Main Business Overview
11.9.5 Quest Diagnostics Inc. Latest Developments
11.10 Bio-Rad Labs Inc.
11.10.1 Bio-Rad Labs Inc. Company Information
11.10.2 Bio-Rad Labs Inc. Point-of-Care Infectious Disease Diagnostics & Testing Product Offered
11.10.3 Bio-Rad Labs Inc. Point-of-Care Infectious Disease Diagnostics & Testing Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Bio-Rad Labs Inc. Main Business Overview
11.10.5 Bio-Rad Labs Inc. Latest Developments
11.11 bioMйrieux SA
11.11.1 bioMйrieux SA Company Information
11.11.2 bioMйrieux SA Point-of-Care Infectious Disease Diagnostics & Testing Product Offered
11.11.3 bioMйrieux SA Point-of-Care Infectious Disease Diagnostics & Testing Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 bioMйrieux SA Main Business Overview
11.11.5 bioMйrieux SA Latest Developments
11.12 Sight Diagnostics Ltd.
11.12.1 Sight Diagnostics Ltd. Company Information
11.12.2 Sight Diagnostics Ltd. Point-of-Care Infectious Disease Diagnostics & Testing Product Offered
11.12.3 Sight Diagnostics Ltd. Point-of-Care Infectious Disease Diagnostics & Testing Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Sight Diagnostics Ltd. Main Business Overview
11.12.5 Sight Diagnostics Ltd. Latest Developments
11.13 Gene POC
11.13.1 Gene POC Company Information
11.13.2 Gene POC Point-of-Care Infectious Disease Diagnostics & Testing Product Offered
11.13.3 Gene POC Point-of-Care Infectious Disease Diagnostics & Testing Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Gene POC Main Business Overview
11.13.5 Gene POC Latest Developments
11.14 Trivitron Healthcare
11.14.1 Trivitron Healthcare Company Information
11.14.2 Trivitron Healthcare Point-of-Care Infectious Disease Diagnostics & Testing Product Offered
11.14.3 Trivitron Healthcare Point-of-Care Infectious Disease Diagnostics & Testing Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 Trivitron Healthcare Main Business Overview
11.14.5 Trivitron Healthcare Latest Developments
11.15 OJ-Bio Ltd.
11.15.1 OJ-Bio Ltd. Company Information
11.15.2 OJ-Bio Ltd. Point-of-Care Infectious Disease Diagnostics & Testing Product Offered
11.15.3 OJ-Bio Ltd. Point-of-Care Infectious Disease Diagnostics & Testing Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 OJ-Bio Ltd. Main Business Overview
11.15.5 OJ-Bio Ltd. Latest Developments
11.16 Ortho-Clinical Diagnostics
11.16.1 Ortho-Clinical Diagnostics Company Information
11.16.2 Ortho-Clinical Diagnostics Point-of-Care Infectious Disease Diagnostics & Testing Product Offered
11.16.3 Ortho-Clinical Diagnostics Point-of-Care Infectious Disease Diagnostics & Testing Revenue, Gross Margin and Market Share (2019-2024)
11.16.4 Ortho-Clinical Diagnostics Main Business Overview
11.16.5 Ortho-Clinical Diagnostics Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Point-of-Care Infectious Disease Diagnostics & Testing Market Size 2019-2030
2.1.2 Point-of-Care Infectious Disease Diagnostics & Testing Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Point-of-Care Infectious Disease Diagnostics & Testing Segment by Type
2.2.1 HIV POC
2.2.2 Clostridium difficile POC
2.2.3 HBV POC
2.2.4 Pneumonia or Streptococcus associated infections
2.2.5 Respiratory syncytial virus (RSV) POC
2.2.6 HPV POC
2.2.7 Influenza/Flu POC
2.2.8 Other Infectious Disease POC
2.3 Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Type
2.3.1 Point-of-Care Infectious Disease Diagnostics & Testing Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Point-of-Care Infectious Disease Diagnostics & Testing Market Size Market Share by Type (2019-2024)
2.4 Point-of-Care Infectious Disease Diagnostics & Testing Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Home
2.4.4 Assisted Living Healthcare Facilities
2.4.5 Laboratories
2.4.6 Others
2.5 Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Application
2.5.1 Point-of-Care Infectious Disease Diagnostics & Testing Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Point-of-Care Infectious Disease Diagnostics & Testing Market Size Market Share by Application (2019-2024)
3 POINT-OF-CARE INFECTIOUS DISEASE DIAGNOSTICS & TESTING MARKET SIZE BY PLAYER
3.1 Point-of-Care Infectious Disease Diagnostics & Testing Market Size Market Share by Players
3.1.1 Global Point-of-Care Infectious Disease Diagnostics & Testing Revenue by Players (2019-2024)
3.1.2 Global Point-of-Care Infectious Disease Diagnostics & Testing Revenue Market Share by Players (2019-2024)
3.2 Global Point-of-Care Infectious Disease Diagnostics & Testing Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 POINT-OF-CARE INFECTIOUS DISEASE DIAGNOSTICS & TESTING BY REGIONS
4.1 Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Regions (2019-2024)
4.2 Americas Point-of-Care Infectious Disease Diagnostics & Testing Market Size Growth (2019-2024)
4.3 APAC Point-of-Care Infectious Disease Diagnostics & Testing Market Size Growth (2019-2024)
4.4 Europe Point-of-Care Infectious Disease Diagnostics & Testing Market Size Growth (2019-2024)
4.5 Middle East & Africa Point-of-Care Infectious Disease Diagnostics & Testing Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Country (2019-2024)
5.2 Americas Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Type (2019-2024)
5.3 Americas Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Region (2019-2024)
6.2 APAC Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Type (2019-2024)
6.3 APAC Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Point-of-Care Infectious Disease Diagnostics & Testing by Country (2019-2024)
7.2 Europe Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Type (2019-2024)
7.3 Europe Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Point-of-Care Infectious Disease Diagnostics & Testing by Region (2019-2024)
8.2 Middle East & Africa Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Type (2019-2024)
8.3 Middle East & Africa Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL POINT-OF-CARE INFECTIOUS DISEASE DIAGNOSTICS & TESTING MARKET FORECAST
10.1 Global Point-of-Care Infectious Disease Diagnostics & Testing Forecast by Regions (2025-2030)
10.1.1 Global Point-of-Care Infectious Disease Diagnostics & Testing Forecast by Regions (2025-2030)
10.1.2 Americas Point-of-Care Infectious Disease Diagnostics & Testing Forecast
10.1.3 APAC Point-of-Care Infectious Disease Diagnostics & Testing Forecast
10.1.4 Europe Point-of-Care Infectious Disease Diagnostics & Testing Forecast
10.1.5 Middle East & Africa Point-of-Care Infectious Disease Diagnostics & Testing Forecast
10.2 Americas Point-of-Care Infectious Disease Diagnostics & Testing Forecast by Country (2025-2030)
10.2.1 United States Point-of-Care Infectious Disease Diagnostics & Testing Market Forecast
10.2.2 Canada Point-of-Care Infectious Disease Diagnostics & Testing Market Forecast
10.2.3 Mexico Point-of-Care Infectious Disease Diagnostics & Testing Market Forecast
10.2.4 Brazil Point-of-Care Infectious Disease Diagnostics & Testing Market Forecast
10.3 APAC Point-of-Care Infectious Disease Diagnostics & Testing Forecast by Region (2025-2030)
10.3.1 China Point-of-Care Infectious Disease Diagnostics & Testing Market Forecast
10.3.2 Japan Point-of-Care Infectious Disease Diagnostics & Testing Market Forecast
10.3.3 Korea Point-of-Care Infectious Disease Diagnostics & Testing Market Forecast
10.3.4 Southeast Asia Point-of-Care Infectious Disease Diagnostics & Testing Market Forecast
10.3.5 India Point-of-Care Infectious Disease Diagnostics & Testing Market Forecast
10.3.6 Australia Point-of-Care Infectious Disease Diagnostics & Testing Market Forecast
10.4 Europe Point-of-Care Infectious Disease Diagnostics & Testing Forecast by Country (2025-2030)
10.4.1 Germany Point-of-Care Infectious Disease Diagnostics & Testing Market Forecast
10.4.2 France Point-of-Care Infectious Disease Diagnostics & Testing Market Forecast
10.4.3 UK Point-of-Care Infectious Disease Diagnostics & Testing Market Forecast
10.4.4 Italy Point-of-Care Infectious Disease Diagnostics & Testing Market Forecast
10.4.5 Russia Point-of-Care Infectious Disease Diagnostics & Testing Market Forecast
10.5 Middle East & Africa Point-of-Care Infectious Disease Diagnostics & Testing Forecast by Region (2025-2030)
10.5.1 Egypt Point-of-Care Infectious Disease Diagnostics & Testing Market Forecast
10.5.2 South Africa Point-of-Care Infectious Disease Diagnostics & Testing Market Forecast
10.5.3 Israel Point-of-Care Infectious Disease Diagnostics & Testing Market Forecast
10.5.4 Turkey Point-of-Care Infectious Disease Diagnostics & Testing Market Forecast
10.5.5 GCC Countries Point-of-Care Infectious Disease Diagnostics & Testing Market Forecast
10.6 Global Point-of-Care Infectious Disease Diagnostics & Testing Forecast by Type (2025-2030)
10.7 Global Point-of-Care Infectious Disease Diagnostics & Testing Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Abbott
11.1.1 Abbott Company Information
11.1.2 Abbott Point-of-Care Infectious Disease Diagnostics & Testing Product Offered
11.1.3 Abbott Point-of-Care Infectious Disease Diagnostics & Testing Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Abbott Main Business Overview
11.1.5 Abbott Latest Developments
11.2 Thermo Fisher Scientific Inc
11.2.1 Thermo Fisher Scientific Inc Company Information
11.2.2 Thermo Fisher Scientific Inc Point-of-Care Infectious Disease Diagnostics & Testing Product Offered
11.2.3 Thermo Fisher Scientific Inc Point-of-Care Infectious Disease Diagnostics & Testing Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Thermo Fisher Scientific Inc Main Business Overview
11.2.5 Thermo Fisher Scientific Inc Latest Developments
11.3 Roche
11.3.1 Roche Company Information
11.3.2 Roche Point-of-Care Infectious Disease Diagnostics & Testing Product Offered
11.3.3 Roche Point-of-Care Infectious Disease Diagnostics & Testing Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Roche Main Business Overview
11.3.5 Roche Latest Developments
11.4 Siemens Healthineers
11.4.1 Siemens Healthineers Company Information
11.4.2 Siemens Healthineers Point-of-Care Infectious Disease Diagnostics & Testing Product Offered
11.4.3 Siemens Healthineers Point-of-Care Infectious Disease Diagnostics & Testing Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Siemens Healthineers Main Business Overview
11.4.5 Siemens Healthineers Latest Developments
11.5 BD & Company
11.5.1 BD & Company Company Information
11.5.2 BD & Company Point-of-Care Infectious Disease Diagnostics & Testing Product Offered
11.5.3 BD & Company Point-of-Care Infectious Disease Diagnostics & Testing Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 BD & Company Main Business Overview
11.5.5 BD & Company Latest Developments
11.6 Chembio Diagnostics Inc.
11.6.1 Chembio Diagnostics Inc. Company Information
11.6.2 Chembio Diagnostics Inc. Point-of-Care Infectious Disease Diagnostics & Testing Product Offered
11.6.3 Chembio Diagnostics Inc. Point-of-Care Infectious Disease Diagnostics & Testing Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Chembio Diagnostics Inc. Main Business Overview
11.6.5 Chembio Diagnostics Inc. Latest Developments
11.7 Trinity Biotech
11.7.1 Trinity Biotech Company Information
11.7.2 Trinity Biotech Point-of-Care Infectious Disease Diagnostics & Testing Product Offered
11.7.3 Trinity Biotech Point-of-Care Infectious Disease Diagnostics & Testing Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Trinity Biotech Main Business Overview
11.7.5 Trinity Biotech Latest Developments
11.8 Cardinal Health
11.8.1 Cardinal Health Company Information
11.8.2 Cardinal Health Point-of-Care Infectious Disease Diagnostics & Testing Product Offered
11.8.3 Cardinal Health Point-of-Care Infectious Disease Diagnostics & Testing Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Cardinal Health Main Business Overview
11.8.5 Cardinal Health Latest Developments
11.9 Quest Diagnostics Inc.
11.9.1 Quest Diagnostics Inc. Company Information
11.9.2 Quest Diagnostics Inc. Point-of-Care Infectious Disease Diagnostics & Testing Product Offered
11.9.3 Quest Diagnostics Inc. Point-of-Care Infectious Disease Diagnostics & Testing Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Quest Diagnostics Inc. Main Business Overview
11.9.5 Quest Diagnostics Inc. Latest Developments
11.10 Bio-Rad Labs Inc.
11.10.1 Bio-Rad Labs Inc. Company Information
11.10.2 Bio-Rad Labs Inc. Point-of-Care Infectious Disease Diagnostics & Testing Product Offered
11.10.3 Bio-Rad Labs Inc. Point-of-Care Infectious Disease Diagnostics & Testing Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Bio-Rad Labs Inc. Main Business Overview
11.10.5 Bio-Rad Labs Inc. Latest Developments
11.11 bioMйrieux SA
11.11.1 bioMйrieux SA Company Information
11.11.2 bioMйrieux SA Point-of-Care Infectious Disease Diagnostics & Testing Product Offered
11.11.3 bioMйrieux SA Point-of-Care Infectious Disease Diagnostics & Testing Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 bioMйrieux SA Main Business Overview
11.11.5 bioMйrieux SA Latest Developments
11.12 Sight Diagnostics Ltd.
11.12.1 Sight Diagnostics Ltd. Company Information
11.12.2 Sight Diagnostics Ltd. Point-of-Care Infectious Disease Diagnostics & Testing Product Offered
11.12.3 Sight Diagnostics Ltd. Point-of-Care Infectious Disease Diagnostics & Testing Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Sight Diagnostics Ltd. Main Business Overview
11.12.5 Sight Diagnostics Ltd. Latest Developments
11.13 Gene POC
11.13.1 Gene POC Company Information
11.13.2 Gene POC Point-of-Care Infectious Disease Diagnostics & Testing Product Offered
11.13.3 Gene POC Point-of-Care Infectious Disease Diagnostics & Testing Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Gene POC Main Business Overview
11.13.5 Gene POC Latest Developments
11.14 Trivitron Healthcare
11.14.1 Trivitron Healthcare Company Information
11.14.2 Trivitron Healthcare Point-of-Care Infectious Disease Diagnostics & Testing Product Offered
11.14.3 Trivitron Healthcare Point-of-Care Infectious Disease Diagnostics & Testing Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 Trivitron Healthcare Main Business Overview
11.14.5 Trivitron Healthcare Latest Developments
11.15 OJ-Bio Ltd.
11.15.1 OJ-Bio Ltd. Company Information
11.15.2 OJ-Bio Ltd. Point-of-Care Infectious Disease Diagnostics & Testing Product Offered
11.15.3 OJ-Bio Ltd. Point-of-Care Infectious Disease Diagnostics & Testing Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 OJ-Bio Ltd. Main Business Overview
11.15.5 OJ-Bio Ltd. Latest Developments
11.16 Ortho-Clinical Diagnostics
11.16.1 Ortho-Clinical Diagnostics Company Information
11.16.2 Ortho-Clinical Diagnostics Point-of-Care Infectious Disease Diagnostics & Testing Product Offered
11.16.3 Ortho-Clinical Diagnostics Point-of-Care Infectious Disease Diagnostics & Testing Revenue, Gross Margin and Market Share (2019-2024)
11.16.4 Ortho-Clinical Diagnostics Main Business Overview
11.16.5 Ortho-Clinical Diagnostics Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Point-of-Care Infectious Disease Diagnostics & Testing Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of HIV POC
Table 3. Major Players of Clostridium difficile POC
Table 4. Major Players of HBV POC
Table 5. Major Players of Pneumonia or Streptococcus associated infections
Table 6. Major Players of Respiratory syncytial virus (RSV) POC
Table 7. Major Players of HPV POC
Table 8. Major Players of Influenza/Flu POC
Table 9. Major Players of Other Infectious Disease POC
Table 10. Point-of-Care Infectious Disease Diagnostics & Testing Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 11. Global Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Type (2019-2024) & ($ Millions)
Table 12. Global Point-of-Care Infectious Disease Diagnostics & Testing Market Size Market Share by Type (2019-2024)
Table 13. Point-of-Care Infectious Disease Diagnostics & Testing Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 14. Global Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Application (2019-2024) & ($ Millions)
Table 15. Global Point-of-Care Infectious Disease Diagnostics & Testing Market Size Market Share by Application (2019-2024)
Table 16. Global Point-of-Care Infectious Disease Diagnostics & Testing Revenue by Players (2019-2024) & ($ Millions)
Table 17. Global Point-of-Care Infectious Disease Diagnostics & Testing Revenue Market Share by Player (2019-2024)
Table 18. Point-of-Care Infectious Disease Diagnostics & Testing Key Players Head office and Products Offered
Table 19. Point-of-Care Infectious Disease Diagnostics & Testing Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 20. New Products and Potential Entrants
Table 21. Mergers & Acquisitions, Expansion
Table 22. Global Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Regions 2019-2024 & ($ Millions)
Table 23. Global Point-of-Care Infectious Disease Diagnostics & Testing Market Size Market Share by Regions (2019-2024)
Table 24. Global Point-of-Care Infectious Disease Diagnostics & Testing Revenue by Country/Region (2019-2024) & ($ millions)
Table 25. Global Point-of-Care Infectious Disease Diagnostics & Testing Revenue Market Share by Country/Region (2019-2024)
Table 26. Americas Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Country (2019-2024) & ($ Millions)
Table 27. Americas Point-of-Care Infectious Disease Diagnostics & Testing Market Size Market Share by Country (2019-2024)
Table 28. Americas Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Type (2019-2024) & ($ Millions)
Table 29. Americas Point-of-Care Infectious Disease Diagnostics & Testing Market Size Market Share by Type (2019-2024)
Table 30. Americas Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Application (2019-2024) & ($ Millions)
Table 31. Americas Point-of-Care Infectious Disease Diagnostics & Testing Market Size Market Share by Application (2019-2024)
Table 32. APAC Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Region (2019-2024) & ($ Millions)
Table 33. APAC Point-of-Care Infectious Disease Diagnostics & Testing Market Size Market Share by Region (2019-2024)
Table 34. APAC Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Type (2019-2024) & ($ Millions)
Table 35. APAC Point-of-Care Infectious Disease Diagnostics & Testing Market Size Market Share by Type (2019-2024)
Table 36. APAC Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Application (2019-2024) & ($ Millions)
Table 37. APAC Point-of-Care Infectious Disease Diagnostics & Testing Market Size Market Share by Application (2019-2024)
Table 38. Europe Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Country (2019-2024) & ($ Millions)
Table 39. Europe Point-of-Care Infectious Disease Diagnostics & Testing Market Size Market Share by Country (2019-2024)
Table 40. Europe Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Type (2019-2024) & ($ Millions)
Table 41. Europe Point-of-Care Infectious Disease Diagnostics & Testing Market Size Market Share by Type (2019-2024)
Table 42. Europe Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Application (2019-2024) & ($ Millions)
Table 43. Europe Point-of-Care Infectious Disease Diagnostics & Testing Market Size Market Share by Application (2019-2024)
Table 44. Middle East & Africa Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Region (2019-2024) & ($ Millions)
Table 45. Middle East & Africa Point-of-Care Infectious Disease Diagnostics & Testing Market Size Market Share by Region (2019-2024)
Table 46. Middle East & Africa Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Type (2019-2024) & ($ Millions)
Table 47. Middle East & Africa Point-of-Care Infectious Disease Diagnostics & Testing Market Size Market Share by Type (2019-2024)
Table 48. Middle East & Africa Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Application (2019-2024) & ($ Millions)
Table 49. Middle East & Africa Point-of-Care Infectious Disease Diagnostics & Testing Market Size Market Share by Application (2019-2024)
Table 50. Key Market Drivers & Growth Opportunities of Point-of-Care Infectious Disease Diagnostics & Testing
Table 51. Key Market Challenges & Risks of Point-of-Care Infectious Disease Diagnostics & Testing
Table 52. Key Industry Trends of Point-of-Care Infectious Disease Diagnostics & Testing
Table 53. Global Point-of-Care Infectious Disease Diagnostics & Testing Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 54. Global Point-of-Care Infectious Disease Diagnostics & Testing Market Size Market Share Forecast by Regions (2025-2030)
Table 55. Global Point-of-Care Infectious Disease Diagnostics & Testing Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 56. Global Point-of-Care Infectious Disease Diagnostics & Testing Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 57. Abbott Details, Company Type, Point-of-Care Infectious Disease Diagnostics & Testing Area Served and Its Competitors
Table 58. Abbott Point-of-Care Infectious Disease Diagnostics & Testing Product Offered
Table 59. Abbott Point-of-Care Infectious Disease Diagnostics & Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 60. Abbott Main Business
Table 61. Abbott Latest Developments
Table 62. Thermo Fisher Scientific Inc Details, Company Type, Point-of-Care Infectious Disease Diagnostics & Testing Area Served and Its Competitors
Table 63. Thermo Fisher Scientific Inc Point-of-Care Infectious Disease Diagnostics & Testing Product Offered
Table 64. Thermo Fisher Scientific Inc Main Business
Table 65. Thermo Fisher Scientific Inc Point-of-Care Infectious Disease Diagnostics & Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 66. Thermo Fisher Scientific Inc Latest Developments
Table 67. Roche Details, Company Type, Point-of-Care Infectious Disease Diagnostics & Testing Area Served and Its Competitors
Table 68. Roche Point-of-Care Infectious Disease Diagnostics & Testing Product Offered
Table 69. Roche Main Business
Table 70. Roche Point-of-Care Infectious Disease Diagnostics & Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 71. Roche Latest Developments
Table 72. Siemens Healthineers Details, Company Type, Point-of-Care Infectious Disease Diagnostics & Testing Area Served and Its Competitors
Table 73. Siemens Healthineers Point-of-Care Infectious Disease Diagnostics & Testing Product Offered
Table 74. Siemens Healthineers Main Business
Table 75. Siemens Healthineers Point-of-Care Infectious Disease Diagnostics & Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 76. Siemens Healthineers Latest Developments
Table 77. BD & Company Details, Company Type, Point-of-Care Infectious Disease Diagnostics & Testing Area Served and Its Competitors
Table 78. BD & Company Point-of-Care Infectious Disease Diagnostics & Testing Product Offered
Table 79. BD & Company Main Business
Table 80. BD & Company Point-of-Care Infectious Disease Diagnostics & Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 81. BD & Company Latest Developments
Table 82. Chembio Diagnostics Inc. Details, Company Type, Point-of-Care Infectious Disease Diagnostics & Testing Area Served and Its Competitors
Table 83. Chembio Diagnostics Inc. Point-of-Care Infectious Disease Diagnostics & Testing Product Offered
Table 84. Chembio Diagnostics Inc. Main Business
Table 85. Chembio Diagnostics Inc. Point-of-Care Infectious Disease Diagnostics & Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 86. Chembio Diagnostics Inc. Latest Developments
Table 87. Trinity Biotech Details, Company Type, Point-of-Care Infectious Disease Diagnostics & Testing Area Served and Its Competitors
Table 88. Trinity Biotech Point-of-Care Infectious Disease Diagnostics & Testing Product Offered
Table 89. Trinity Biotech Main Business
Table 90. Trinity Biotech Point-of-Care Infectious Disease Diagnostics & Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 91. Trinity Biotech Latest Developments
Table 92. Cardinal Health Details, Company Type, Point-of-Care Infectious Disease Diagnostics & Testing Area Served and Its Competitors
Table 93. Cardinal Health Point-of-Care Infectious Disease Diagnostics & Testing Product Offered
Table 94. Cardinal Health Main Business
Table 95. Cardinal Health Point-of-Care Infectious Disease Diagnostics & Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 96. Cardinal Health Latest Developments
Table 97. Quest Diagnostics Inc. Details, Company Type, Point-of-Care Infectious Disease Diagnostics & Testing Area Served and Its Competitors
Table 98. Quest Diagnostics Inc. Point-of-Care Infectious Disease Diagnostics & Testing Product Offered
Table 99. Quest Diagnostics Inc. Main Business
Table 100. Quest Diagnostics Inc. Point-of-Care Infectious Disease Diagnostics & Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 101. Quest Diagnostics Inc. Latest Developments
Table 102. Bio-Rad Labs Inc. Details, Company Type, Point-of-Care Infectious Disease Diagnostics & Testing Area Served and Its Competitors
Table 103. Bio-Rad Labs Inc. Point-of-Care Infectious Disease Diagnostics & Testing Product Offered
Table 104. Bio-Rad Labs Inc. Main Business
Table 105. Bio-Rad Labs Inc. Point-of-Care Infectious Disease Diagnostics & Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 106. Bio-Rad Labs Inc. Latest Developments
Table 107. bioMйrieux SA Details, Company Type, Point-of-Care Infectious Disease Diagnostics & Testing Area Served and Its Competitors
Table 108. bioMйrieux SA Point-of-Care Infectious Disease Diagnostics & Testing Product Offered
Table 109. bioMйrieux SA Point-of-Care Infectious Disease Diagnostics & Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 110. bioMйrieux SA Main Business
Table 111. bioMйrieux SA Latest Developments
Table 112. Sight Diagnostics Ltd. Details, Company Type, Point-of-Care Infectious Disease Diagnostics & Testing Area Served and Its Competitors
Table 113. Sight Diagnostics Ltd. Point-of-Care Infectious Disease Diagnostics & Testing Product Offered
Table 114. Sight Diagnostics Ltd. Main Business
Table 115. Sight Diagnostics Ltd. Point-of-Care Infectious Disease Diagnostics & Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 116. Sight Diagnostics Ltd. Latest Developments
Table 117. Gene POC Details, Company Type, Point-of-Care Infectious Disease Diagnostics & Testing Area Served and Its Competitors
Table 118. Gene POC Point-of-Care Infectious Disease Diagnostics & Testing Product Offered
Table 119. Gene POC Main Business
Table 120. Gene POC Point-of-Care Infectious Disease Diagnostics & Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 121. Gene POC Latest Developments
Table 122. Trivitron Healthcare Details, Company Type, Point-of-Care Infectious Disease Diagnostics & Testing Area Served and Its Competitors
Table 123. Trivitron Healthcare Point-of-Care Infectious Disease Diagnostics & Testing Product Offered
Table 124. Trivitron Healthcare Main Business
Table 125. Trivitron Healthcare Point-of-Care Infectious Disease Diagnostics & Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 126. Trivitron Healthcare Latest Developments
Table 127. OJ-Bio Ltd. Details, Company Type, Point-of-Care Infectious Disease Diagnostics & Testing Area Served and Its Competitors
Table 128. OJ-Bio Ltd. Point-of-Care Infectious Disease Diagnostics & Testing Product Offered
Table 129. OJ-Bio Ltd. Main Business
Table 130. OJ-Bio Ltd. Point-of-Care Infectious Disease Diagnostics & Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 131. OJ-Bio Ltd. Latest Developments
Table 132. Ortho-Clinical Diagnostics Details, Company Type, Point-of-Care Infectious Disease Diagnostics & Testing Area Served and Its Competitors
Table 133. Ortho-Clinical Diagnostics Point-of-Care Infectious Disease Diagnostics & Testing Product Offered
Table 134. Ortho-Clinical Diagnostics Main Business
Table 135. Ortho-Clinical Diagnostics Point-of-Care Infectious Disease Diagnostics & Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 136. Ortho-Clinical Diagnostics Latest Developments
Table 1. Point-of-Care Infectious Disease Diagnostics & Testing Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of HIV POC
Table 3. Major Players of Clostridium difficile POC
Table 4. Major Players of HBV POC
Table 5. Major Players of Pneumonia or Streptococcus associated infections
Table 6. Major Players of Respiratory syncytial virus (RSV) POC
Table 7. Major Players of HPV POC
Table 8. Major Players of Influenza/Flu POC
Table 9. Major Players of Other Infectious Disease POC
Table 10. Point-of-Care Infectious Disease Diagnostics & Testing Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 11. Global Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Type (2019-2024) & ($ Millions)
Table 12. Global Point-of-Care Infectious Disease Diagnostics & Testing Market Size Market Share by Type (2019-2024)
Table 13. Point-of-Care Infectious Disease Diagnostics & Testing Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 14. Global Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Application (2019-2024) & ($ Millions)
Table 15. Global Point-of-Care Infectious Disease Diagnostics & Testing Market Size Market Share by Application (2019-2024)
Table 16. Global Point-of-Care Infectious Disease Diagnostics & Testing Revenue by Players (2019-2024) & ($ Millions)
Table 17. Global Point-of-Care Infectious Disease Diagnostics & Testing Revenue Market Share by Player (2019-2024)
Table 18. Point-of-Care Infectious Disease Diagnostics & Testing Key Players Head office and Products Offered
Table 19. Point-of-Care Infectious Disease Diagnostics & Testing Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 20. New Products and Potential Entrants
Table 21. Mergers & Acquisitions, Expansion
Table 22. Global Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Regions 2019-2024 & ($ Millions)
Table 23. Global Point-of-Care Infectious Disease Diagnostics & Testing Market Size Market Share by Regions (2019-2024)
Table 24. Global Point-of-Care Infectious Disease Diagnostics & Testing Revenue by Country/Region (2019-2024) & ($ millions)
Table 25. Global Point-of-Care Infectious Disease Diagnostics & Testing Revenue Market Share by Country/Region (2019-2024)
Table 26. Americas Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Country (2019-2024) & ($ Millions)
Table 27. Americas Point-of-Care Infectious Disease Diagnostics & Testing Market Size Market Share by Country (2019-2024)
Table 28. Americas Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Type (2019-2024) & ($ Millions)
Table 29. Americas Point-of-Care Infectious Disease Diagnostics & Testing Market Size Market Share by Type (2019-2024)
Table 30. Americas Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Application (2019-2024) & ($ Millions)
Table 31. Americas Point-of-Care Infectious Disease Diagnostics & Testing Market Size Market Share by Application (2019-2024)
Table 32. APAC Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Region (2019-2024) & ($ Millions)
Table 33. APAC Point-of-Care Infectious Disease Diagnostics & Testing Market Size Market Share by Region (2019-2024)
Table 34. APAC Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Type (2019-2024) & ($ Millions)
Table 35. APAC Point-of-Care Infectious Disease Diagnostics & Testing Market Size Market Share by Type (2019-2024)
Table 36. APAC Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Application (2019-2024) & ($ Millions)
Table 37. APAC Point-of-Care Infectious Disease Diagnostics & Testing Market Size Market Share by Application (2019-2024)
Table 38. Europe Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Country (2019-2024) & ($ Millions)
Table 39. Europe Point-of-Care Infectious Disease Diagnostics & Testing Market Size Market Share by Country (2019-2024)
Table 40. Europe Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Type (2019-2024) & ($ Millions)
Table 41. Europe Point-of-Care Infectious Disease Diagnostics & Testing Market Size Market Share by Type (2019-2024)
Table 42. Europe Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Application (2019-2024) & ($ Millions)
Table 43. Europe Point-of-Care Infectious Disease Diagnostics & Testing Market Size Market Share by Application (2019-2024)
Table 44. Middle East & Africa Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Region (2019-2024) & ($ Millions)
Table 45. Middle East & Africa Point-of-Care Infectious Disease Diagnostics & Testing Market Size Market Share by Region (2019-2024)
Table 46. Middle East & Africa Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Type (2019-2024) & ($ Millions)
Table 47. Middle East & Africa Point-of-Care Infectious Disease Diagnostics & Testing Market Size Market Share by Type (2019-2024)
Table 48. Middle East & Africa Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Application (2019-2024) & ($ Millions)
Table 49. Middle East & Africa Point-of-Care Infectious Disease Diagnostics & Testing Market Size Market Share by Application (2019-2024)
Table 50. Key Market Drivers & Growth Opportunities of Point-of-Care Infectious Disease Diagnostics & Testing
Table 51. Key Market Challenges & Risks of Point-of-Care Infectious Disease Diagnostics & Testing
Table 52. Key Industry Trends of Point-of-Care Infectious Disease Diagnostics & Testing
Table 53. Global Point-of-Care Infectious Disease Diagnostics & Testing Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 54. Global Point-of-Care Infectious Disease Diagnostics & Testing Market Size Market Share Forecast by Regions (2025-2030)
Table 55. Global Point-of-Care Infectious Disease Diagnostics & Testing Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 56. Global Point-of-Care Infectious Disease Diagnostics & Testing Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 57. Abbott Details, Company Type, Point-of-Care Infectious Disease Diagnostics & Testing Area Served and Its Competitors
Table 58. Abbott Point-of-Care Infectious Disease Diagnostics & Testing Product Offered
Table 59. Abbott Point-of-Care Infectious Disease Diagnostics & Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 60. Abbott Main Business
Table 61. Abbott Latest Developments
Table 62. Thermo Fisher Scientific Inc Details, Company Type, Point-of-Care Infectious Disease Diagnostics & Testing Area Served and Its Competitors
Table 63. Thermo Fisher Scientific Inc Point-of-Care Infectious Disease Diagnostics & Testing Product Offered
Table 64. Thermo Fisher Scientific Inc Main Business
Table 65. Thermo Fisher Scientific Inc Point-of-Care Infectious Disease Diagnostics & Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 66. Thermo Fisher Scientific Inc Latest Developments
Table 67. Roche Details, Company Type, Point-of-Care Infectious Disease Diagnostics & Testing Area Served and Its Competitors
Table 68. Roche Point-of-Care Infectious Disease Diagnostics & Testing Product Offered
Table 69. Roche Main Business
Table 70. Roche Point-of-Care Infectious Disease Diagnostics & Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 71. Roche Latest Developments
Table 72. Siemens Healthineers Details, Company Type, Point-of-Care Infectious Disease Diagnostics & Testing Area Served and Its Competitors
Table 73. Siemens Healthineers Point-of-Care Infectious Disease Diagnostics & Testing Product Offered
Table 74. Siemens Healthineers Main Business
Table 75. Siemens Healthineers Point-of-Care Infectious Disease Diagnostics & Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 76. Siemens Healthineers Latest Developments
Table 77. BD & Company Details, Company Type, Point-of-Care Infectious Disease Diagnostics & Testing Area Served and Its Competitors
Table 78. BD & Company Point-of-Care Infectious Disease Diagnostics & Testing Product Offered
Table 79. BD & Company Main Business
Table 80. BD & Company Point-of-Care Infectious Disease Diagnostics & Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 81. BD & Company Latest Developments
Table 82. Chembio Diagnostics Inc. Details, Company Type, Point-of-Care Infectious Disease Diagnostics & Testing Area Served and Its Competitors
Table 83. Chembio Diagnostics Inc. Point-of-Care Infectious Disease Diagnostics & Testing Product Offered
Table 84. Chembio Diagnostics Inc. Main Business
Table 85. Chembio Diagnostics Inc. Point-of-Care Infectious Disease Diagnostics & Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 86. Chembio Diagnostics Inc. Latest Developments
Table 87. Trinity Biotech Details, Company Type, Point-of-Care Infectious Disease Diagnostics & Testing Area Served and Its Competitors
Table 88. Trinity Biotech Point-of-Care Infectious Disease Diagnostics & Testing Product Offered
Table 89. Trinity Biotech Main Business
Table 90. Trinity Biotech Point-of-Care Infectious Disease Diagnostics & Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 91. Trinity Biotech Latest Developments
Table 92. Cardinal Health Details, Company Type, Point-of-Care Infectious Disease Diagnostics & Testing Area Served and Its Competitors
Table 93. Cardinal Health Point-of-Care Infectious Disease Diagnostics & Testing Product Offered
Table 94. Cardinal Health Main Business
Table 95. Cardinal Health Point-of-Care Infectious Disease Diagnostics & Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 96. Cardinal Health Latest Developments
Table 97. Quest Diagnostics Inc. Details, Company Type, Point-of-Care Infectious Disease Diagnostics & Testing Area Served and Its Competitors
Table 98. Quest Diagnostics Inc. Point-of-Care Infectious Disease Diagnostics & Testing Product Offered
Table 99. Quest Diagnostics Inc. Main Business
Table 100. Quest Diagnostics Inc. Point-of-Care Infectious Disease Diagnostics & Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 101. Quest Diagnostics Inc. Latest Developments
Table 102. Bio-Rad Labs Inc. Details, Company Type, Point-of-Care Infectious Disease Diagnostics & Testing Area Served and Its Competitors
Table 103. Bio-Rad Labs Inc. Point-of-Care Infectious Disease Diagnostics & Testing Product Offered
Table 104. Bio-Rad Labs Inc. Main Business
Table 105. Bio-Rad Labs Inc. Point-of-Care Infectious Disease Diagnostics & Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 106. Bio-Rad Labs Inc. Latest Developments
Table 107. bioMйrieux SA Details, Company Type, Point-of-Care Infectious Disease Diagnostics & Testing Area Served and Its Competitors
Table 108. bioMйrieux SA Point-of-Care Infectious Disease Diagnostics & Testing Product Offered
Table 109. bioMйrieux SA Point-of-Care Infectious Disease Diagnostics & Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 110. bioMйrieux SA Main Business
Table 111. bioMйrieux SA Latest Developments
Table 112. Sight Diagnostics Ltd. Details, Company Type, Point-of-Care Infectious Disease Diagnostics & Testing Area Served and Its Competitors
Table 113. Sight Diagnostics Ltd. Point-of-Care Infectious Disease Diagnostics & Testing Product Offered
Table 114. Sight Diagnostics Ltd. Main Business
Table 115. Sight Diagnostics Ltd. Point-of-Care Infectious Disease Diagnostics & Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 116. Sight Diagnostics Ltd. Latest Developments
Table 117. Gene POC Details, Company Type, Point-of-Care Infectious Disease Diagnostics & Testing Area Served and Its Competitors
Table 118. Gene POC Point-of-Care Infectious Disease Diagnostics & Testing Product Offered
Table 119. Gene POC Main Business
Table 120. Gene POC Point-of-Care Infectious Disease Diagnostics & Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 121. Gene POC Latest Developments
Table 122. Trivitron Healthcare Details, Company Type, Point-of-Care Infectious Disease Diagnostics & Testing Area Served and Its Competitors
Table 123. Trivitron Healthcare Point-of-Care Infectious Disease Diagnostics & Testing Product Offered
Table 124. Trivitron Healthcare Main Business
Table 125. Trivitron Healthcare Point-of-Care Infectious Disease Diagnostics & Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 126. Trivitron Healthcare Latest Developments
Table 127. OJ-Bio Ltd. Details, Company Type, Point-of-Care Infectious Disease Diagnostics & Testing Area Served and Its Competitors
Table 128. OJ-Bio Ltd. Point-of-Care Infectious Disease Diagnostics & Testing Product Offered
Table 129. OJ-Bio Ltd. Main Business
Table 130. OJ-Bio Ltd. Point-of-Care Infectious Disease Diagnostics & Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 131. OJ-Bio Ltd. Latest Developments
Table 132. Ortho-Clinical Diagnostics Details, Company Type, Point-of-Care Infectious Disease Diagnostics & Testing Area Served and Its Competitors
Table 133. Ortho-Clinical Diagnostics Point-of-Care Infectious Disease Diagnostics & Testing Product Offered
Table 134. Ortho-Clinical Diagnostics Main Business
Table 135. Ortho-Clinical Diagnostics Point-of-Care Infectious Disease Diagnostics & Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 136. Ortho-Clinical Diagnostics Latest Developments
LIST OF FIGURES
Figure 1. Point-of-Care Infectious Disease Diagnostics & Testing Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Point-of-Care Infectious Disease Diagnostics & Testing Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Point-of-Care Infectious Disease Diagnostics & Testing Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Point-of-Care Infectious Disease Diagnostics & Testing Sales Market Share by Country/Region (2023)
Figure 8. Point-of-Care Infectious Disease Diagnostics & Testing Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Point-of-Care Infectious Disease Diagnostics & Testing Market Size Market Share by Type in 2023
Figure 10. Point-of-Care Infectious Disease Diagnostics & Testing in Hospitals
Figure 11. Global Point-of-Care Infectious Disease Diagnostics & Testing Market: Hospitals (2019-2024) & ($ Millions)
Figure 12. Point-of-Care Infectious Disease Diagnostics & Testing in Clinics
Figure 13. Global Point-of-Care Infectious Disease Diagnostics & Testing Market: Clinics (2019-2024) & ($ Millions)
Figure 14. Point-of-Care Infectious Disease Diagnostics & Testing in Home
Figure 15. Global Point-of-Care Infectious Disease Diagnostics & Testing Market: Home (2019-2024) & ($ Millions)
Figure 16. Point-of-Care Infectious Disease Diagnostics & Testing in Assisted Living Healthcare Facilities
Figure 17. Global Point-of-Care Infectious Disease Diagnostics & Testing Market: Assisted Living Healthcare Facilities (2019-2024) & ($ Millions)
Figure 18. Point-of-Care Infectious Disease Diagnostics & Testing in Laboratories
Figure 19. Global Point-of-Care Infectious Disease Diagnostics & Testing Market: Laboratories (2019-2024) & ($ Millions)
Figure 20. Point-of-Care Infectious Disease Diagnostics & Testing in Others
Figure 21. Global Point-of-Care Infectious Disease Diagnostics & Testing Market: Others (2019-2024) & ($ Millions)
Figure 22. Global Point-of-Care Infectious Disease Diagnostics & Testing Market Size Market Share by Application in 2023
Figure 23. Global Point-of-Care Infectious Disease Diagnostics & Testing Revenue Market Share by Player in 2023
Figure 24. Global Point-of-Care Infectious Disease Diagnostics & Testing Market Size Market Share by Regions (2019-2024)
Figure 25. Americas Point-of-Care Infectious Disease Diagnostics & Testing Market Size 2019-2024 ($ Millions)
Figure 26. APAC Point-of-Care Infectious Disease Diagnostics & Testing Market Size 2019-2024 ($ Millions)
Figure 27. Europe Point-of-Care Infectious Disease Diagnostics & Testing Market Size 2019-2024 ($ Millions)
Figure 28. Middle East & Africa Point-of-Care Infectious Disease Diagnostics & Testing Market Size 2019-2024 ($ Millions)
Figure 29. Americas Point-of-Care Infectious Disease Diagnostics & Testing Value Market Share by Country in 2023
Figure 30. United States Point-of-Care Infectious Disease Diagnostics & Testing Market Size Growth 2019-2024 ($ Millions)
Figure 31. Canada Point-of-Care Infectious Disease Diagnostics & Testing Market Size Growth 2019-2024 ($ Millions)
Figure 32. Mexico Point-of-Care Infectious Disease Diagnostics & Testing Market Size Growth 2019-2024 ($ Millions)
Figure 33. Brazil Point-of-Care Infectious Disease Diagnostics & Testing Market Size Growth 2019-2024 ($ Millions)
Figure 34. APAC Point-of-Care Infectious Disease Diagnostics & Testing Market Size Market Share by Region in 2023
Figure 35. APAC Point-of-Care Infectious Disease Diagnostics & Testing Market Size Market Share by Type in 2023
Figure 36. APAC Point-of-Care Infectious Disease Diagnostics & Testing Market Size Market Share by Application in 2023
Figure 37. China Point-of-Care Infectious Disease Diagnostics & Testing Market Size Growth 2019-2024 ($ Millions)
Figure 38. Japan Point-of-Care Infectious Disease Diagnostics & Testing Market Size Growth 2019-2024 ($ Millions)
Figure 39. Korea Point-of-Care Infectious Disease Diagnostics & Testing Market Size Growth 2019-2024 ($ Millions)
Figure 40. Southeast Asia Point-of-Care Infectious Disease Diagnostics & Testing Market Size Growth 2019-2024 ($ Millions)
Figure 41. India Point-of-Care Infectious Disease Diagnostics & Testing Market Size Growth 2019-2024 ($ Millions)
Figure 42. Australia Point-of-Care Infectious Disease Diagnostics & Testing Market Size Growth 2019-2024 ($ Millions)
Figure 43. Europe Point-of-Care Infectious Disease Diagnostics & Testing Market Size Market Share by Country in 2023
Figure 44. Europe Point-of-Care Infectious Disease Diagnostics & Testing Market Size Market Share by Type (2019-2024)
Figure 45. Europe Point-of-Care Infectious Disease Diagnostics & Testing Market Size Market Share by Application (2019-2024)
Figure 46. Germany Point-of-Care Infectious Disease Diagnostics & Testing Market Size Growth 2019-2024 ($ Millions)
Figure 47. France Point-of-Care Infectious Disease Diagnostics & Testing Market Size Growth 2019-2024 ($ Millions)
Figure 48. UK Point-of-Care Infectious Disease Diagnostics & Testing Market Size Growth 2019-2024 ($ Millions)
Figure 49. Italy Point-of-Care Infectious Disease Diagnostics & Testing Market Size Growth 2019-2024 ($ Millions)
Figure 50. Russia Point-of-Care Infectious Disease Diagnostics & Testing Market Size Growth 2019-2024 ($ Millions)
Figure 51. Middle East & Africa Point-of-Care Infectious Disease Diagnostics & Testing Market Size Market Share by Region (2019-2024)
Figure 52. Middle East & Africa Point-of-Care Infectious Disease Diagnostics & Testing Market Size Market Share by Type (2019-2024)
Figure 53. Middle East & Africa Point-of-Care Infectious Disease Diagnostics & Testing Market Size Market Share by Application (2019-2024)
Figure 54. Egypt Point-of-Care Infectious Disease Diagnostics & Testing Market Size Growth 2019-2024 ($ Millions)
Figure 55. South Africa Point-of-Care Infectious Disease Diagnostics & Testing Market Size Growth 2019-2024 ($ Millions)
Figure 56. Israel Point-of-Care Infectious Disease Diagnostics & Testing Market Size Growth 2019-2024 ($ Millions)
Figure 57. Turkey Point-of-Care Infectious Disease Diagnostics & Testing Market Size Growth 2019-2024 ($ Millions)
Figure 58. GCC Country Point-of-Care Infectious Disease Diagnostics & Testing Market Size Growth 2019-2024 ($ Millions)
Figure 59. Americas Point-of-Care Infectious Disease Diagnostics & Testing Market Size 2025-2030 ($ Millions)
Figure 60. APAC Point-of-Care Infectious Disease Diagnostics & Testing Market Size 2025-2030 ($ Millions)
Figure 61. Europe Point-of-Care Infectious Disease Diagnostics & Testing Market Size 2025-2030 ($ Millions)
Figure 62. Middle East & Africa Point-of-Care Infectious Disease Diagnostics & Testing Market Size 2025-2030 ($ Millions)
Figure 63. United States Point-of-Care Infectious Disease Diagnostics & Testing Market Size 2025-2030 ($ Millions)
Figure 64. Canada Point-of-Care Infectious Disease Diagnostics & Testing Market Size 2025-2030 ($ Millions)
Figure 65. Mexico Point-of-Care Infectious Disease Diagnostics & Testing Market Size 2025-2030 ($ Millions)
Figure 66. Brazil Point-of-Care Infectious Disease Diagnostics & Testing Market Size 2025-2030 ($ Millions)
Figure 67. China Point-of-Care Infectious Disease Diagnostics & Testing Market Size 2025-2030 ($ Millions)
Figure 68. Japan Point-of-Care Infectious Disease Diagnostics & Testing Market Size 2025-2030 ($ Millions)
Figure 69. Korea Point-of-Care Infectious Disease Diagnostics & Testing Market Size 2025-2030 ($ Millions)
Figure 70. Southeast Asia Point-of-Care Infectious Disease Diagnostics & Testing Market Size 2025-2030 ($ Millions)
Figure 71. India Point-of-Care Infectious Disease Diagnostics & Testing Market Size 2025-2030 ($ Millions)
Figure 72. Australia Point-of-Care Infectious Disease Diagnostics & Testing Market Size 2025-2030 ($ Millions)
Figure 73. Germany Point-of-Care Infectious Disease Diagnostics & Testing Market Size 2025-2030 ($ Millions)
Figure 74. France Point-of-Care Infectious Disease Diagnostics & Testing Market Size 2025-2030 ($ Millions)
Figure 75. UK Point-of-Care Infectious Disease Diagnostics & Testing Market Size 2025-2030 ($ Millions)
Figure 76. Italy Point-of-Care Infectious Disease Diagnostics & Testing Market Size 2025-2030 ($ Millions)
Figure 77. Russia Point-of-Care Infectious Disease Diagnostics & Testing Market Size 2025-2030 ($ Millions)
Figure 78. Spain Point-of-Care Infectious Disease Diagnostics & Testing Market Size 2025-2030 ($ Millions)
Figure 79. Egypt Point-of-Care Infectious Disease Diagnostics & Testing Market Size 2025-2030 ($ Millions)
Figure 80. South Africa Point-of-Care Infectious Disease Diagnostics & Testing Market Size 2025-2030 ($ Millions)
Figure 81. Israel Point-of-Care Infectious Disease Diagnostics & Testing Market Size 2025-2030 ($ Millions)
Figure 82. Turkey Point-of-Care Infectious Disease Diagnostics & Testing Market Size 2025-2030 ($ Millions)
Figure 83. GCC Countries Point-of-Care Infectious Disease Diagnostics & Testing Market Size 2025-2030 ($ Millions)
Figure 84. Global Point-of-Care Infectious Disease Diagnostics & Testing Market Size Market Share Forecast by Type (2025-2030)
Figure 85. Global Point-of-Care Infectious Disease Diagnostics & Testing Market Size Market Share Forecast by Application (2025-2030)
Figure 1. Point-of-Care Infectious Disease Diagnostics & Testing Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Point-of-Care Infectious Disease Diagnostics & Testing Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Point-of-Care Infectious Disease Diagnostics & Testing Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Point-of-Care Infectious Disease Diagnostics & Testing Sales Market Share by Country/Region (2023)
Figure 8. Point-of-Care Infectious Disease Diagnostics & Testing Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Point-of-Care Infectious Disease Diagnostics & Testing Market Size Market Share by Type in 2023
Figure 10. Point-of-Care Infectious Disease Diagnostics & Testing in Hospitals
Figure 11. Global Point-of-Care Infectious Disease Diagnostics & Testing Market: Hospitals (2019-2024) & ($ Millions)
Figure 12. Point-of-Care Infectious Disease Diagnostics & Testing in Clinics
Figure 13. Global Point-of-Care Infectious Disease Diagnostics & Testing Market: Clinics (2019-2024) & ($ Millions)
Figure 14. Point-of-Care Infectious Disease Diagnostics & Testing in Home
Figure 15. Global Point-of-Care Infectious Disease Diagnostics & Testing Market: Home (2019-2024) & ($ Millions)
Figure 16. Point-of-Care Infectious Disease Diagnostics & Testing in Assisted Living Healthcare Facilities
Figure 17. Global Point-of-Care Infectious Disease Diagnostics & Testing Market: Assisted Living Healthcare Facilities (2019-2024) & ($ Millions)
Figure 18. Point-of-Care Infectious Disease Diagnostics & Testing in Laboratories
Figure 19. Global Point-of-Care Infectious Disease Diagnostics & Testing Market: Laboratories (2019-2024) & ($ Millions)
Figure 20. Point-of-Care Infectious Disease Diagnostics & Testing in Others
Figure 21. Global Point-of-Care Infectious Disease Diagnostics & Testing Market: Others (2019-2024) & ($ Millions)
Figure 22. Global Point-of-Care Infectious Disease Diagnostics & Testing Market Size Market Share by Application in 2023
Figure 23. Global Point-of-Care Infectious Disease Diagnostics & Testing Revenue Market Share by Player in 2023
Figure 24. Global Point-of-Care Infectious Disease Diagnostics & Testing Market Size Market Share by Regions (2019-2024)
Figure 25. Americas Point-of-Care Infectious Disease Diagnostics & Testing Market Size 2019-2024 ($ Millions)
Figure 26. APAC Point-of-Care Infectious Disease Diagnostics & Testing Market Size 2019-2024 ($ Millions)
Figure 27. Europe Point-of-Care Infectious Disease Diagnostics & Testing Market Size 2019-2024 ($ Millions)
Figure 28. Middle East & Africa Point-of-Care Infectious Disease Diagnostics & Testing Market Size 2019-2024 ($ Millions)
Figure 29. Americas Point-of-Care Infectious Disease Diagnostics & Testing Value Market Share by Country in 2023
Figure 30. United States Point-of-Care Infectious Disease Diagnostics & Testing Market Size Growth 2019-2024 ($ Millions)
Figure 31. Canada Point-of-Care Infectious Disease Diagnostics & Testing Market Size Growth 2019-2024 ($ Millions)
Figure 32. Mexico Point-of-Care Infectious Disease Diagnostics & Testing Market Size Growth 2019-2024 ($ Millions)
Figure 33. Brazil Point-of-Care Infectious Disease Diagnostics & Testing Market Size Growth 2019-2024 ($ Millions)
Figure 34. APAC Point-of-Care Infectious Disease Diagnostics & Testing Market Size Market Share by Region in 2023
Figure 35. APAC Point-of-Care Infectious Disease Diagnostics & Testing Market Size Market Share by Type in 2023
Figure 36. APAC Point-of-Care Infectious Disease Diagnostics & Testing Market Size Market Share by Application in 2023
Figure 37. China Point-of-Care Infectious Disease Diagnostics & Testing Market Size Growth 2019-2024 ($ Millions)
Figure 38. Japan Point-of-Care Infectious Disease Diagnostics & Testing Market Size Growth 2019-2024 ($ Millions)
Figure 39. Korea Point-of-Care Infectious Disease Diagnostics & Testing Market Size Growth 2019-2024 ($ Millions)
Figure 40. Southeast Asia Point-of-Care Infectious Disease Diagnostics & Testing Market Size Growth 2019-2024 ($ Millions)
Figure 41. India Point-of-Care Infectious Disease Diagnostics & Testing Market Size Growth 2019-2024 ($ Millions)
Figure 42. Australia Point-of-Care Infectious Disease Diagnostics & Testing Market Size Growth 2019-2024 ($ Millions)
Figure 43. Europe Point-of-Care Infectious Disease Diagnostics & Testing Market Size Market Share by Country in 2023
Figure 44. Europe Point-of-Care Infectious Disease Diagnostics & Testing Market Size Market Share by Type (2019-2024)
Figure 45. Europe Point-of-Care Infectious Disease Diagnostics & Testing Market Size Market Share by Application (2019-2024)
Figure 46. Germany Point-of-Care Infectious Disease Diagnostics & Testing Market Size Growth 2019-2024 ($ Millions)
Figure 47. France Point-of-Care Infectious Disease Diagnostics & Testing Market Size Growth 2019-2024 ($ Millions)
Figure 48. UK Point-of-Care Infectious Disease Diagnostics & Testing Market Size Growth 2019-2024 ($ Millions)
Figure 49. Italy Point-of-Care Infectious Disease Diagnostics & Testing Market Size Growth 2019-2024 ($ Millions)
Figure 50. Russia Point-of-Care Infectious Disease Diagnostics & Testing Market Size Growth 2019-2024 ($ Millions)
Figure 51. Middle East & Africa Point-of-Care Infectious Disease Diagnostics & Testing Market Size Market Share by Region (2019-2024)
Figure 52. Middle East & Africa Point-of-Care Infectious Disease Diagnostics & Testing Market Size Market Share by Type (2019-2024)
Figure 53. Middle East & Africa Point-of-Care Infectious Disease Diagnostics & Testing Market Size Market Share by Application (2019-2024)
Figure 54. Egypt Point-of-Care Infectious Disease Diagnostics & Testing Market Size Growth 2019-2024 ($ Millions)
Figure 55. South Africa Point-of-Care Infectious Disease Diagnostics & Testing Market Size Growth 2019-2024 ($ Millions)
Figure 56. Israel Point-of-Care Infectious Disease Diagnostics & Testing Market Size Growth 2019-2024 ($ Millions)
Figure 57. Turkey Point-of-Care Infectious Disease Diagnostics & Testing Market Size Growth 2019-2024 ($ Millions)
Figure 58. GCC Country Point-of-Care Infectious Disease Diagnostics & Testing Market Size Growth 2019-2024 ($ Millions)
Figure 59. Americas Point-of-Care Infectious Disease Diagnostics & Testing Market Size 2025-2030 ($ Millions)
Figure 60. APAC Point-of-Care Infectious Disease Diagnostics & Testing Market Size 2025-2030 ($ Millions)
Figure 61. Europe Point-of-Care Infectious Disease Diagnostics & Testing Market Size 2025-2030 ($ Millions)
Figure 62. Middle East & Africa Point-of-Care Infectious Disease Diagnostics & Testing Market Size 2025-2030 ($ Millions)
Figure 63. United States Point-of-Care Infectious Disease Diagnostics & Testing Market Size 2025-2030 ($ Millions)
Figure 64. Canada Point-of-Care Infectious Disease Diagnostics & Testing Market Size 2025-2030 ($ Millions)
Figure 65. Mexico Point-of-Care Infectious Disease Diagnostics & Testing Market Size 2025-2030 ($ Millions)
Figure 66. Brazil Point-of-Care Infectious Disease Diagnostics & Testing Market Size 2025-2030 ($ Millions)
Figure 67. China Point-of-Care Infectious Disease Diagnostics & Testing Market Size 2025-2030 ($ Millions)
Figure 68. Japan Point-of-Care Infectious Disease Diagnostics & Testing Market Size 2025-2030 ($ Millions)
Figure 69. Korea Point-of-Care Infectious Disease Diagnostics & Testing Market Size 2025-2030 ($ Millions)
Figure 70. Southeast Asia Point-of-Care Infectious Disease Diagnostics & Testing Market Size 2025-2030 ($ Millions)
Figure 71. India Point-of-Care Infectious Disease Diagnostics & Testing Market Size 2025-2030 ($ Millions)
Figure 72. Australia Point-of-Care Infectious Disease Diagnostics & Testing Market Size 2025-2030 ($ Millions)
Figure 73. Germany Point-of-Care Infectious Disease Diagnostics & Testing Market Size 2025-2030 ($ Millions)
Figure 74. France Point-of-Care Infectious Disease Diagnostics & Testing Market Size 2025-2030 ($ Millions)
Figure 75. UK Point-of-Care Infectious Disease Diagnostics & Testing Market Size 2025-2030 ($ Millions)
Figure 76. Italy Point-of-Care Infectious Disease Diagnostics & Testing Market Size 2025-2030 ($ Millions)
Figure 77. Russia Point-of-Care Infectious Disease Diagnostics & Testing Market Size 2025-2030 ($ Millions)
Figure 78. Spain Point-of-Care Infectious Disease Diagnostics & Testing Market Size 2025-2030 ($ Millions)
Figure 79. Egypt Point-of-Care Infectious Disease Diagnostics & Testing Market Size 2025-2030 ($ Millions)
Figure 80. South Africa Point-of-Care Infectious Disease Diagnostics & Testing Market Size 2025-2030 ($ Millions)
Figure 81. Israel Point-of-Care Infectious Disease Diagnostics & Testing Market Size 2025-2030 ($ Millions)
Figure 82. Turkey Point-of-Care Infectious Disease Diagnostics & Testing Market Size 2025-2030 ($ Millions)
Figure 83. GCC Countries Point-of-Care Infectious Disease Diagnostics & Testing Market Size 2025-2030 ($ Millions)
Figure 84. Global Point-of-Care Infectious Disease Diagnostics & Testing Market Size Market Share Forecast by Type (2025-2030)
Figure 85. Global Point-of-Care Infectious Disease Diagnostics & Testing Market Size Market Share Forecast by Application (2025-2030)
